Loss of DAXX/ATRX Protein Expression Results in Ischemia Resistance and Radiation Sensitivity in Pancreatic Neuroendocrine Tumor Cells and Is Associated with Improved Response to Trans-Arterial Radioembolization
Neuroendocrinology · 2025
DOI: 10.1159/000547041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroendocrinology, 2025. Verfasst von Puzzuoli und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Co-Repressor Proteins, Radiation Tolerance, Neuroendocrine Tumors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Introduction
Metastatic liver pancreatic neuroendocrine tumors (PNETs) can be treated with ischemia-based trans-arterial embolization/trans-arterial chemo-embolization or radiation-based trans-arterial radioembolization (TARE). Guidelines for treatment selection are limited. The purpose of this study was to measure the effect of loss of DAXX/ATRX protein expression on ischemia and radiation sensitivity in Bon-1 and QGP-1 cells, and to compare TARE response in PNETs with and without a DAXX/ATRX mutation.
Methods
This was a laboratory investigation and retrospective review of an institutional database of TARE-treated PNET patients. Ischemia and radiation sensitivity were tested on Bon-1 and QGP-1 cells and CRISPR-generated DAXX (C16/C45) and ATRX (QAX12/QAX24) knockouts. Post-ischemia and postradiation cell viability, survival fraction, and caspase-3 expression were measured. Local progression-free survival (LPFS) was measured from time of TARE to local progression or death and estimated using Cox proportional hazards.
Results
Post-ischemia DAXX (C16/C45) and ATRX (QAX12/QAX24) knockouts had increased cell viability compared with Bon-1 wild-type cells (p < 0.0001, days 3, 5) and QGP-1 wild-type cells (p < 0.0001, days 3, 5, 7). Postradiation C16/C45 and QAX12/QAX24 had decreased survival fraction compared with respective wild type (p < 0.0001, all cell lines). C16/C45 had decreased apoptotic activity post-ischemia and increased apoptotic activity postradiation compared with wild type (p < 0.0001, all cell lines). Presence of DAXX/ATRX mutation was associated with longer LPFS after TARE (p < 0.001). Median LPFS after TARE was 6 months in wild type compared with 22 months in patients with DAXX/ATRX mutation.
Conclusion
Loss of DAXX/ATRX protein expression is associated with ischemia resistance and radiation sensitivity in Bon-1 and QGP-1 cells and longer LPFS after TARE in PNET patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Molecular Cytology Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Medicine, Boston Medical Center and University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Puzzuoli, Solivio, C., Yuan, G., Rizzo, A. J., Graham, M. K., Shenker, L., Vista, W., Gil, A., Singh, H., Alexander, E., Gonzalez-Aguirre, A., Latzman, J., Petre, E. N., Yarmohammadi, H., Erinjeri, J. P., Covey, A., Chan, E., Russell, J., Bodei, L., …, & Ziv, E. (2025). Loss of DAXX/ATRX Protein Expression Results in Ischemia Resistance and Radiation Sensitivity in Pancreatic Neuroendocrine Tumor Cells and Is Associated with Improved Response to Trans-Arterial Radioembolization. Neuroendocrinology. https://doi.org/10.1159/000547041
Vancouver
Puzzuoli, Solivio C, Yuan G, Rizzo AJ, Graham MK, Shenker L, et al. Loss of DAXX/ATRX Protein Expression Results in Ischemia Resistance and Radiation Sensitivity in Pancreatic Neuroendocrine Tumor Cells and Is Associated with Improved Response to Trans-Arterial Radioembolization. Neuroendocrinology. 2025. doi:10.1159/000547041
BibTeX
@article{Puzzuoli2025,
author = {Puzzuoli, Puzzuoli and Solivio, Caleb and Yuan, Gavin and Rizzo, Anthony J and Graham, Mindy K and Shenker, Larissa and Vista, Will and Gil, Adam and Singh, Himanshu and Alexander, Erica and Gonzalez-Aguirre, Adrian and Latzman, Jonathan and Petre, E Nadia and Yarmohammadi, Hooman and Erinjeri, Joseph P and Covey, Anne and Chan, Eric and Russell, James and Bodei, Lisa and Raj, Nitya and Reidy-Lagunes, Diane and Heaphy, Christopher M and Ziv, Etay},
title = {Loss of DAXX/ATRX Protein Expression Results in Ischemia Resistance and Radiation Sensitivity in Pancreatic Neuroendocrine Tumor Cells and Is Associated with Improved Response to Trans-Arterial Radioembolization},
journal = {Neuroendocrinology},
year = {2025},
doi = {10.1159/000547041}
}
EUVIMED